Evidence map›Paper›PMID 39209993›Full record

ArticleNature plants2024

A chemical approach to extend flower longevity of Japanese morning glory via inhibition of master senescence regulator EPHEMERAL1.

Kenichi Shibuya, Akira Nozawa, Chikako Takahashi, Tatsuya Sawasaki

Abstract read
PubMed Publisher
In one paragraph

Article in Nature plants, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kenichi ShibuyaInstitute of Vegetable and Floriculture Science, National Agriculture and Food Research Organization (NARO), Tsukuba, Japan. shibuken@affrc.go.jp.ORCID http://orcid.org/0000-0002-2915-9651
Akira NozawaProteo-Science Center (PROS), Ehime University, Matsuyama, Japan. nozawa.akira.my@ehime-u.ac.jp.ORCID http://orcid.org/0000-0003-4886-0213
Chikako TakahashiProteo-Science Center (PROS), Ehime University, Matsuyama, Japan.
Tatsuya SawasakiProteo-Science Center (PROS), Ehime University, Matsuyama, Japan.ORCID http://orcid.org/0000-0002-7952-0556

Funding

Japan Agency for Medical Research and Development (AMED) JP21am0101077Japan Agency for Medical Research and Development (AMED) JP21am0101086MEXT | Japan Society for the Promotion of Science (JSPS) 19K05815MEXT | Japan Society for the Promotion of Science (JSPS) 21K05589MEXT | Japan Society for the Promotion of Science (JSPS) JP16H06579MEXT | Japan Society for the Promotion of Science (JSPS) JP19H03218Ministry of Agriculture, Forestry and Fisheries (Ministry of Agriculture, Forestry and Fisheries of Japan) N/A
6 · The paper itself

Abstract

Petal senescence in flowering plants is a type of programmed cell death with highly regulated onset and progression. A NAM/ATAF1,2/CUC2 transcription factor, EPHEMERAL1 (EPH1), has been identified as a key regulator of petal senescence in Japanese morning glory (Ipomoea nil). Here we used a novel chemical approach to delay petal senescence in Japanese morning glory by inhibiting the DNA-binding activity of EPH1. A cell-free high-throughput screening system and subsequent bioassays found two tetrafluorophthalimide-based compounds, Everlastin1 and Everlastin2, that inhibited the EPH1-DNA interaction and delayed petal senescence. The inhibitory mechanism was due to the suppression of EPH1 dimerization. RNA-sequencing analysis revealed that the chemical treatment strongly suppressed the expression of programmed cell death- and autophagy-related genes. These results suggest that a chemical approach targeting a transcription factor can regulate petal senescence.

Indexed as

FlowersIpomoea nilPlant ProteinsTranscription FactorsGene Expression Regulation, PlantPlant SenescencePlant ProteinsTranscription Factors

Identifiers

PMID39209993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.